{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:40:28Z","timestamp":1791229228767,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Circular RNAs (circRNAs) have emerged as important regulators in cancer biology, but their roles in acute myeloid leukemia (AML) remain poorly characterized due to limited sample sizes and technical challenges in RNA sequencing. Here, we analyze RNA-sequencing data from 315 Swedish AML patients to create the most comprehensive circRNA profile in AML to date. We identify 5,711 high-confidence circRNAs across 315 AML samples, including 402 differentially expressed between AML and healthy controls, with host genes enriched in hematopoietic pathways. We further discover two circRNAs including hsa_circ_0024048 (p\u2009=\u20092.16\u00d710\u207b\u2076, FDR\u2009=\u20090.012) and hsa_circ_0084678 (p\u2009=\u20091.33\u00d710\u207b\u2075, FDR\u2009=\u20090.075) whose high expression is associated with significantly improved overall survival, a relationship not observed in their respective host genes. Furthermore, these circRNAs are associated with sensitivities of several drugs, as validated in external datasets (p\u2009&lt;\u20090.05). We identify 451 circRNAs with ELN2022 risk group\u2013specific expression patterns, highlighting circRNA heterogeneity. Subtype analysis further reveals that hsa_circ_0080850 is specifically associated with worse survival (p\u2009=\u20092.13\u00d710\u207b\n                    <jats:sup>5<\/jats:sup>\n                    and lower remission rates (38.9% vs 74.7%) within the ELN2022 Favorable subgroup. To conclude, this study establishes the most comprehensive circRNA landscape in AML to date and demonstrates their potential as biomarkers and therapeutic targets, suggesting further investigation into circRNA-driven precision medicine in AML.\n                  <\/jats:p>","DOI":"10.1038\/s41698-026-01357-6","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:16:29Z","timestamp":1772738189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Landscape of circular RNAs in acute myeloid leukemia and their clinical significance"],"prefix":"10.1038","volume":"10","author":[{"given":"Thi-Hau","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manh-Hung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Nam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Erkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"\u00d6stling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bohlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"\u00d6sterroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozbeh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas M.","family":"Orre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Kallioniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Pawitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Nghia","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1357_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J. Hematol. Oncol. J. Hematol. Oncol. 12, 51 (2019).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41375-023-01844-w","volume":"37","author":"S Arza-Apalategi","year":"2023","unstructured":"Arza-Apalategi, S. et al. High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia. Leukemia 37, 901\u2013904 (2023).","journal-title":"Leukemia"},{"key":"1357_CR4","doi-asserted-by":"publisher","first-page":"18679","DOI":"10.1073\/pnas.1422050112","volume":"111","author":"R Garzon","year":"2014","unstructured":"Garzon, R. et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 111, 18679\u201318684 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1357_CR5","doi-asserted-by":"publisher","first-page":"15535","DOI":"10.1073\/pnas.0808266105","volume":"105","author":"Z Li","year":"2008","unstructured":"Li, Z. et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. USA 105, 15535\u201315540 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-018-0596-2","volume":"11","author":"AS Mer","year":"2018","unstructured":"Mer, A. S. et al. Expression levels of long non-coding RNAs are prognostic for AML outcome. J. Hematol. Oncol. J. Hematol. Oncol. 11, 52 (2018).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"1357_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41417-025-00954-0","volume":"32","author":"E Cozzi","year":"2025","unstructured":"Cozzi, E. et al. MALNC: a new mutant NPM1\/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response. Cancer Gene Ther. 32, 1191\u20131205 (2025).","journal-title":"Cancer Gene Ther."},{"key":"1357_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","volume":"14","author":"KK Ebbesen","year":"2017","unstructured":"Ebbesen, K. K., Hansen, T. B. & Kjems, J. Insights into circular RNA biology. RNA Biol. 14, 1035\u20131045 (2017).","journal-title":"RNA Biol."},{"key":"1357_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen, L. S., Jakobsen, T., Hager, H. & Kjems, J. The emerging roles of circRNAs in cancer and oncology. Nat. Rev. Clin. Oncol. 19, 188\u2013206 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1357_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384\u2013388 (2013).","journal-title":"Nature"},{"key":"1357_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/bloodadvances.2020003230","volume":"5","author":"S Lux","year":"2021","unstructured":"Lux, S. et al. Deregulated expression of circular RNAs in acute myeloid leukemia. Blood Adv. 5, 1490\u20131503 (2021).","journal-title":"Blood Adv."},{"key":"1357_CR12","doi-asserted-by":"publisher","first-page":"216880","DOI":"10.1016\/j.canlet.2024.216880","volume":"591","author":"H Sun","year":"2024","unstructured":"Sun, H. et al. circRNAs as prognostic markers in pediatric acute myeloid leukemia. Cancer Lett. 591, 216880 (2024).","journal-title":"Cancer Lett."},{"key":"1357_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1182\/bloodadvances.2019000568","volume":"4","author":"D Papaioannou","year":"2020","unstructured":"Papaioannou, D. et al. Clinical and functional significance of circular RNAs in cytogenetically normal AML. Blood Adv. 4, 239\u2013251 (2020).","journal-title":"Blood Adv."},{"key":"1357_CR14","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3324\/haematol.2017.172866","volume":"102","author":"S Hirsch","year":"2017","unstructured":"Hirsch, S. et al. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia. Haematologica 102, 2039\u20132047 (2017).","journal-title":"Haematologica"},{"key":"1357_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2019000802","volume":"134","author":"Y-M Sun","year":"2019","unstructured":"Sun, Y.-M. et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood 134, 1533\u20131546 (2019).","journal-title":"Blood"},{"key":"1357_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526 (2018).","journal-title":"Nature"},{"key":"1357_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly, D. et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell 40, 850\u2013864 (2022).","journal-title":"Cancer Cell"},{"key":"1357_CR18","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TCGA-Network, T. C. G. A. R","year":"2013","unstructured":"TCGA-Network, T. C. G. A. R Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1357_CR19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/leu.2017.48","volume":"31","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Leukemia 31, 2029\u20132036 (2017).","journal-title":"Leukemia"},{"key":"1357_CR20","doi-asserted-by":"crossref","unstructured":"Nguyen, D. et al. Circall: fast and accurate methodology for discovery of circular RNAs from paired-end RNA-sequencing data. BMC Bioinformatics 22, 495 (2021).","DOI":"10.1186\/s12859-021-04418-8"},{"key":"1357_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/bib\/bbx014","volume":"19","author":"Y Gao","year":"2018","unstructured":"Gao, Y., Zhang, J. & Zhao, F. Circular RNA identification based on multiple seed matching. Brief. Bioinform. 19, 803\u2013810 (2018).","journal-title":"Brief. Bioinform."},{"key":"1357_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333\u2013338 (2013).","journal-title":"Nature"},{"key":"1357_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa054","volume":"9","author":"Z Cai","year":"2020","unstructured":"Cai, Z. et al. FCIRC: a comprehensive pipeline for the exploration of fusion linear and circular RNAs. GigaScience 9, giaa054 (2020).","journal-title":"GigaScience"},{"key":"1357_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41388-025-03299-y","volume":"44","author":"L Yao","year":"2025","unstructured":"Yao, L. et al. circAFF2 promotes the development of AML by binding to PML mRNA. Oncogene 44, 1234\u20131244 (2025).","journal-title":"Oncogene"},{"key":"1357_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep05193","volume":"4","author":"B Yadav","year":"2014","unstructured":"Yadav, B. et al. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci. Rep. 4, 5193 (2014).","journal-title":"Sci. Rep."},{"key":"1357_CR26","doi-asserted-by":"publisher","first-page":"68851","DOI":"10.18632\/oncotarget.11998","volume":"7","author":"TN Vu","year":"2016","unstructured":"Vu, T. N. et al. Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer. Oncotarget 7, 68851\u201368863 (2016).","journal-title":"Oncotarget"},{"key":"1357_CR27","doi-asserted-by":"crossref","unstructured":"Mou, T. et al. The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia. Am. J. Hematol. 96, 580\u2013588 (2021).","DOI":"10.1002\/ajh.26141"},{"key":"1357_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"1357_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."},{"key":"1357_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","volume":"12","author":"D Malani","year":"2022","unstructured":"Malani, D. et al. Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer Discov. 12, 388\u2013401 (2022).","journal-title":"Cancer Discov."},{"key":"1357_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005420","volume":"13","author":"X Zeng","year":"2017","unstructured":"Zeng, X., Lin, W., Guo, M. & Zou, Q. A comprehensive overview and evaluation of circular RNA detection tools. PLoS Comput. Biol. 13, e1005420 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"1357_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08329-7","volume":"23","author":"MH Nguyen","year":"2022","unstructured":"Nguyen, M. H., Nguyen, H.-N. & Vu, T. N. Evaluation of methods to detect circular RNAs from single-end RNA-sequencing data. BMC Genomics 23, 106 (2022).","journal-title":"BMC Genomics"},{"key":"1357_CR33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41592-023-01944-6","volume":"20","author":"M Vromman","year":"2023","unstructured":"Vromman, M. et al. Large-scale benchmarking of circRNA detection tools reveals large differences in sensitivity but not in precision. Nat. Methods 20, 1159\u20131169 (2023).","journal-title":"Nat. Methods"},{"key":"1357_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05646-4","volume":"25","author":"T-H Nguyen","year":"2024","unstructured":"Nguyen, T.-H., Nguyen, H.-N. & Vu, T. N. CircNetVis: an interactive web application for visualizing interaction networks of circular RNAs. BMC Bioinforma. 25, 31 (2024).","journal-title":"BMC Bioinforma."},{"key":"1357_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1357_CR36","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Parmigiani, G. & Johnson, W. E. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genomics Bioinforma. 2, lqaa078 (2020).","journal-title":"NAR Genomics Bioinforma."},{"key":"1357_CR37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1357_CR38","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/bioinformatics\/bti626","volume":"21","author":"Y Pawitan","year":"2005","unstructured":"Pawitan, Y., Murthy, K. R. K., Michiels, S. & Ploner, A. Bias in the estimation of false discovery rate in microarray studies. Bioinformatics 21, 3865\u20133872 (2005).","journal-title":"Bioinformatics"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01357-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01357-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01357-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:07:35Z","timestamp":1773770855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01357-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01357-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}